Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Viral Inactivation Market?

The size of the viral inactivation market has shown robust growth in the past few years. It is projected to increase from $5.01 billion in 2024 to $5.48 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.4%. The historical period’s growth can be associated with factors such as global air traffic surge, advanced navigation systems, commercial aviation development, airline cost efficiency, boosted flight safety, and decreased pilot workload.

What Growth Rate Is Forecasted for the Viral Inactivation Market by 2029?

The market size for viral inactivation is projected to experience a swift expansion in the coming years. The estimations point towards a growth that will reach “$8.28 billion by 2029”, marking a Compound Annual Growth Rate (CAGR) of 10.9%. The increase in the anticipated period owes its credit to advancements in autonomous flight technology, designing of future-generation aircrafts, commitment towards greener aviation, progress in urban air mobility (uam), and growing requirements for aircrafts. The period of forecast displays prominent trends such as incorporation of advanced avionics, application of artificial intelligence, human-machine interface (hmi) advancements, modification of existing aircrafts, and integration of global navigation satellite system (gnss).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

Which Key Companies Are Shaping the Future of the Viral Inactivation Market?

Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited

Which Factors Are Driving Demand in the Viral Inactivation Industry?

The surge in the occurrence of numerous infectious illnesses is anticipated to boost the viral inactivation market’s expansion. These diseases, transmissible via contaminated food and drink, or pathogens like viruses, bacteria, fungi, and parasites, refer to conditions that spread from one person to another. Viral inactivation, the utilization of physical and chemical disinfectants to deactivate viruses, is extensively used in human disease management, therefore contributing considerably to the market’s development. For instance, in March 2024, the US’s national public health agency, the Centers for Disease Control and Prevention, reported that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, signifying an increase of 1,295 cases. The rate also grew from 2.5 per 100,000 people in 2022 to 2.9 in 2023. Consequently, the increasing infectious disease incidences are fuelling the expansion of the viral inactivation market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10401&type=smp

How Is the Viral Inactivation Market Segmented by Several Divisions?

The viral inactivation market covered in this report is segmented –

1) By Product: Kits And Reagents, Systems, Services

2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

Subsegments:

1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

3) By Services: Viral Testing Services, Validation Services, Consulting Services

What are the Emerging Market Trends Driving the Growth of the Viral Inactivation Industry?

There is a rising trend of companies in the viral inactivation market incorporating high-end technological processes, bolstering their market standing. An example of this was seen in March 2022, when WuXi Advanced Therapies, a fully-owned subsidiary of WuXi AppTec, a biopharmaceutical company from China, unveiled the Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This state-of-the-art technology accelerates the approval of new treatments by carrying out simultaneous assay formulation, biosafety checks, viral clearing, product launch, and testing internally. This highly innovative approach provides a new way to produce adeno-associated virus (AAV) of Good Manufacturing Practices (GMP) grade without necessitating transfection.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

Which Regions Are Driving Growth in the Viral Inactivation Market?

North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401

This Report Delivers Insight On:

1. How big is the viral inactivation market, and how is it changing globally?

2. Who are the major companies in the viral inactivation market, and how are they performing?

3. What are the key opportunities and risks in the viral inactivation market right now?

4. Which products or customer segments are growing the most in the viral inactivation market?

5. What factors are helping or slowing down the growth of the viral inactivation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model